Catherine Wheeler

A phase II study of high-dose cyclophosphamide, thiotepa, and carboplatin with autologous marrow support in women with measurable advanced breast cancer responding to standard-dose therapy.

Karen H. Antman, Lois Ayash, Anthony Elias et al. · Journal of Clinical Oncology · 1992 · 374 citations

Medicine, Oncology, Pharmacotherapy +17

Clinical evaluation of ZD6474, an orally active inhibitor of VEGF and EGF receptor signaling, in patients with solid, malignant tumors

Scott N. Holden, Sabine Eckhardt, R. Basser et al. · Annals of Oncology · 2005 · 306 citations · Full text

Medicine, Oncology, Pharmacology +15

Mobilization of peripheral blood progenitor cells by chemotherapy and granulocyte-macrophage colony-stimulating factor for hematologic support after high-dose intensification for breast cancer

AD Elias, Lois Ayash, KC Anderson et al. · Blood · 1992 · 260 citations · Full text

Medicine, Hematology, Oncology +17

Treatment of severe veno-occlusive disease with defibrotide: compassionate use results in response without significant toxicity in a high-risk population.

Paul G. Richardson, Anthony Elias, Amrita Krishnan et al. · PubMed · 1998 · 254 citations

Medicine, Pharmacology, Pharmacotherapy +4

Ricolinostat, the First Selective Histone Deacetylase 6 Inhibitor, in Combination with Bortezomib and Dexamethasone for Relapsed or Refractory Multiple Myeloma

Dan T. Vogl, Noopur Raje, Sundar Jagannath et al. · Clinical Cancer Research · 2017 · 251 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17